Publications by authors named "Wenle Ye"

Claim this Profile
U
Ultrathin Diaphragm Curved Piezoelectric Micromachined Ultrasound Transducers Enabling 2.5V Low Voltage Artery Monitoring.
Xiaofan Hu, Yongquan Ma, Yuewu Gong, Hao Li, Wei Pang, Wenle Ye

IEEE Trans Biomed Eng· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis.
Wenle Ye, Yanchun Zhao, Yutong Zhou, Jiansong Huang, Xiao He

Mol Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.
Jiajia Pan, Yungui Wang, Shujuan Huang, Shihui Mao, Qing Ling, Wenle Ye

J Mol Med (Berl)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ferroptosis landscape in acute myeloid leukemia.
Zhixin Ma, Wenle Ye, Xin Huang, Xia Li, Fenglin Li

Aging (Albany NY)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
circSLC25A13 acts as a ceRNA to regulate AML progression via miR-616-3p/ADCY2 axis.
Wenwen Wei, Jiajia Pan, Jinghan Wang, Shihui Mao, Yu Qian, Wenle Ye

Mol Carcinog· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/β-catenin signaling by palmitoylation modification.
Wenle Ye, Jinghan Wang, Jiansong Huang, Xiao He, Zhixin Ma

Front Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression.
Zhixin Ma, Wenle Ye, Jinghan Wang, Xin Huang, Jiansong Huang

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD.
Yu Qian, Xiang Zhang, Shihui Mao, Wenwen Wei, Xiangjie Lin, Wenle Ye

Mol Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML.
Qing Ling, Shihui Mao, Jiajia Pan, Wenwen Wei, Yu Qian, Wenle Ye

Cancer Biomark· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia.
Fenglin Li, Qing Ling, Jiaying Lian, Ying Chen, Chao Hu, Wenle Ye

Cancer Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis.
Shihui Mao, Yu Qian, Wenwen Wei, Xiangjie Lin, Qing Ling, Wenle Ye

Ann Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis.
Fenglin Li, Wenle Ye, Yiyi Yao, Wenwen Wei, Xiangjie Lin

J Transl Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance.
Fenglin Li, Qing Ling, Chao Hu, Huafeng Wang, Wenle Ye

J Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia.
Wenwen Wei, Shujuan Huang, Qing Ling, Shihui Mao, Yu Qian, Wenle Ye

J Transl Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis.
Jiansong Huang, Xin Huang, Yang Li, Xia Li, Jinghan Wang, Wenle Ye

Front Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Features and Prognostic Significance of Mutations in Diffuse Large B-Cell Lymphoma.
Zhongqi Li, Fang Yu, Wenle Ye, Liping Mao, Jiansong Huang

Front Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway.
Qing Ling, Fenglin Li, Xiang Zhang, Shihui Mao, Xiangjie Lin, Wenle Ye

EBioMedicine· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study.
Xiangjie Lin, Jinghan Wang, Xin Huang, Huafeng Wang, Fenglin Li, Wenle Ye

Aging (Albany NY)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199.
Shihui Mao, Qing Ling, Jiajia Pan, Fenglin Li, Shujuan Huang, Wenle Ye

J Transl Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation.
Jiansong Huang, Shujuan Huang, Zhixin Ma, Xiangjie Lin, Xia Li, Wenle Ye

Thromb Haemost· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia.
Jinghan Wang, Jiajia Pan, Shujuan Huang, Fenglin Li, Jiansong Huang, Wenle Ye

BMC Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia.
Xia Lin, Qing Ling, Yunfei Lv, Wenle Ye, Jiansong Huang

Cancer Biomark· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner.
Shujuan Huang, Chenying Li, Xiang Zhang, Jiajia Pan, Fenglin Li, Wenle Ye

Mol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel SAHA‑bendamustine hybrid NL‑101 in combination with daunorubicin synergistically suppresses acute myeloid leukemia.
Jingrui Jin, Xia Li, Wenjian Guo, Fenglin Li, Jiansong Huang, Wenle Ye

Oncol Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia.
Shujuan Huang, Jiajia Pan, Jing Jin, Chengying Li, Xia Li, Wenle Ye

Cancer Lett· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis